Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01326624 · ClinicalTrials.gov registry record
Study of the Wearable Defibrillator in Heart-Failure Patients
A clinical trial, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- 25
- Enrollment target
NCT01326624 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 25 participants.
The verdict
NCT01326624 has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and efficacy of wearable defibrillator use in patients with left ventricular dysfunction or advanced heart failure symptoms, who have a high-risk for sudden cardiac death but are either not eligible for an implantable defibrillator under current guidelines or are not able to receive the device due to their condition.
Interventions
- DEVICE wearable defibrillator (LifeVest)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-03 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01326624
The ClinicalTrials.gov registry entry for NCT01326624 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which wearable defibrillator (LifeVest) is the first listed.
NCT01326624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01326624 about?
NCT01326624 is a clinical study titled "Study of the Wearable Defibrillator in Heart-Failure Patients". The purpose of the study is to evaluate the safety and efficacy of wearable defibrillator use in patients with left ventricular dysfunction or advanced heart failure symptoms, who have a high-risk for sudden cardiac death but are either not eligible for an implantable defibrillator under current gui...
What is the current status of trial NCT01326624?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2011-03. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01326624?
The interventions under investigation include: wearable defibrillator (LifeVest) (DEVICE).
Who is sponsoring clinical trial NCT01326624?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.